Literature DB >> 13650568

[Experiences of pre- and postoperative evaluation of mitral stenosis].

H KOCH, H SCHMUTZLER, W SCHMITZ.   

Abstract

Entities:  

Keywords:  MITRAL STENOSIS/surgery

Mesh：

Year:  1959        PMID： 13650568

Source DB:  PubMed          Journal:  Arch Kreislaufforsch        ISSN： 0003-9217


× No keyword cloud information.
  27 in total

1.  Rheumatic restenosis of mitral valve; report of a case with death almost five years after mitral valvulotomy.

Authors:  V A McKUSICK
Journal:  AMA Arch Intern Med       Date:  1955-04

2.  The size of the left atrium in conditions other than mitral valve disease.

Authors:  B W COBBS; J P SHILLINGFORD; R E STEINER
Journal:  Br Heart J       Date:  1957-10

3.  [Surgical experiences in 100 cases of operated mitral stenosis].

Authors:  F LINDER; W SCHMITZ; H KOCH; H SCHMUTZLER
Journal:  Chirurg       Date:  1958-04       Impact factor: 0.955

4.  [Mitral stenosis, pathophysiology, clinical picture and surgical therapy].

Authors:  F SCHAUB; P H ROSSIER
Journal:  Helv Med Acta       Date:  1957-11

5.  Diagnosis of rheumatic fever and like conditions; evaluation of certain of the acute phase reactants in a single specimen of blood.

Authors:  F H ADAMS
Journal:  Calif Med       Date:  1956-08

6.  Mitral valvotomy; a progress report.

Authors:  H R FRASER; R W TURNER
Journal:  Lancet       Date:  1956-09-15       Impact factor: 79.321

7.  Nature of rheumatic fever.

Authors:  M MCCARTY
Journal:  Circulation       Date:  1956-12       Impact factor: 29.690

8.  [Indications for surgical treatment of mitral stenosis].

Authors:  B SCHLEGEL
Journal:  Arztl Wochensch       Date:  1956-07-27

9.  Reactivation of rheumatic fever following mitral commissurotomy.

Authors:  E H FELL; R T HELMEN
Journal:  AMA Arch Surg       Date:  1955-10

10.  The role of the streptococcus in the pathogenesis of rheumatic fever.

Authors:  F J CATANZARO; C A STETSON; A J MORRIS; R CHAMOVITZ; C H RAMMELKAMP; B L STOLZER; W D PERRY
Journal:  Am J Med       Date:  1954-12       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.